Clin2
NCT06406140Likely a fitEnrolling by invitation

Niacin for cholesterol and phosphate in dialysis patients

End-stage Renal Disease

Treatments studied

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tests whether a vitamin called niacin can help lower a type of cholesterol (Lp(a)) and reduce high phosphate levels in people on hemodialysis. It may offer a new way to improve heart and bone health for dialysis patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have been on hemodialysis for at least 3 months
  • You are not pregnant or breastfeeding
  • You do not have an active peptic ulcer or history of severe allergy to niacin
  • You are willing to take part in the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07004725Not yet recruiting· Phase 2
Niacin therapy for rheumatoid arthritis

This trial tests whether adding niacin (a vitamin) to your current treatment can help manage rheumatoid arthritis while also improving cholesterol levels. It might be an option if you have stable RA and mild to moderate cholesterol issues.

NCT07693543Not yet recruiting· Phase 2
Nicotinamide riboside supplement for chronic kidney disease

This trial tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3) can help people with moderate chronic kidney disease. It aims to see if it can slow down kidney function decline and improve overall health.

San Diego, California
NCT03573089Recruiting
Testing higher vs standard phosphate targets in dialysis patients

This trial compares two treatment goals for blood phosphate levels in people with end-stage kidney disease who are on dialysis. It may help determine which target is safer and works better in real-world care.

Camperdown, New South Wales
NCT07368946Recruiting
Phosphate study for people with kidney disease

This study looks at how the body handles phosphate in people with chronic kidney disease. It may help researchers understand how to better manage phosphate levels to improve health.

Dallas, Texas
NCT07080840Enrolling by invitation
Phosphorus education and medication help for dialysis patients

This trial tests a program to help hemodialysis patients better understand phosphorus control and stick to their phosphate-binding medications. It aims to improve health outcomes by supporting patients who have been on dialysis for over a year.

Taichung
NCT07730385Not yet recruiting
Fish oil and heart health in dialysis patients

This study is looking at whether fish oil supplements can improve the function of 'good' cholesterol (HDL) in people who are on maintenance hemodialysis. If you are a stable dialysis patient, you may be able to join to help researchers understand how fish oil affects heart and blood vessel health.

Vienna, State of Vienna

Hear when a new End Stage Renal Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.